
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About


Dentsply Sirona Inc (XRAY)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: XRAY (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit -13.81% | Avg. Invested days 25 | Today’s Advisory WEAK BUY |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.73B USD | Price to earnings Ratio - | 1Y Target Price 22.23 |
Price to earnings Ratio - | 1Y Target Price 22.23 | ||
Volume (30-day avg) 2365696 | Beta 0.97 | 52 Weeks Range 17.07 - 34.02 | Updated Date 02/21/2025 |
52 Weeks Range 17.07 - 34.02 | Updated Date 02/21/2025 | ||
Dividends yield (FY) 3.42% | Basic EPS (TTM) -2.03 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-02-26 | When Before Market | Estimate - | Actual - |
Profitability
Profit Margin -10.59% | Operating Margin (TTM) 6.94% |
Management Effectiveness
Return on Assets (TTM) 2.32% | Return on Equity (TTM) -13.99% |
Valuation
Trailing PE - | Forward PE 9.61 | Enterprise Value 5748930324 | Price to Sales(TTM) 0.96 |
Enterprise Value 5748930324 | Price to Sales(TTM) 0.96 | ||
Enterprise Value to Revenue 1.47 | Enterprise Value to EBITDA 91.25 | Shares Outstanding 198780000 | Shares Floating 197962584 |
Shares Outstanding 198780000 | Shares Floating 197962584 | ||
Percent Insiders 0.68 | Percent Institutions 105.75 |
AI Summary
Dentsply Sirona Inc. (XRAY): A Comprehensive Overview
Company Profile:
Detailed History and Background:
Founded in 1899, Dentsply Sirona Inc. (XRAY) is a leading manufacturer and distributor of dental products and technologies. Originally known as Dentsply International, the company merged with Sirona in 2016 to create the current entity. Dentsply Sirona boasts a global presence, with operations in over 40 countries and a workforce of approximately 15,000 employees.
Core Business Areas:
Dentsply Sirona's core business areas encompass a wide range of dental solutions, including:
- Consumables: This segment offers a vast array of single-use products like restorative materials, endodontic instruments, and infection control solutions.
- Equipment: This segment focuses on the development and manufacturing of advanced dental equipment, such as digital imaging systems, CAD/CAM systems, and dental chairs.
- Implants: This segment specializes in dental implant systems, including implants, abutments, and prosthetic components.
- Orthodontics: This segment provides orthodontic products, including brackets, wires, and aligners, for correcting teeth misalignment.
Leadership Team and Corporate Structure:
Dentsply Sirona is led by CEO Simon Campion, who joined the company in 2019. The executive leadership team also includes CFO Jorge Gomez, President of Implants Jochen Peh, and President of Consumables/Technology & Equipment Michael Geil. The company operates under a decentralized structure with dedicated business units for each core area.
Top Products and Market Share:
Top Products:
- Surefil one-step composite: A leading light-cured composite for filling cavities.
- Primescan intraoral scanner: A digital impression system for accurate and efficient dental scans.
- Axeos 3D imaging system: A high-quality 3D imaging platform for diagnostics and treatment planning.
- Atlantis abutments: Customized abutments for dental implants, offering high precision and aesthetic results.
- Incognito lingual braces: Nearly invisible braces for discreet orthodontic treatment.
Market Share:
Dentsply Sirona holds a significant market share in various dental product categories, particularly in the consumables and equipment segments. The company estimates its global market share to be approximately 17% for consumables and 12% for equipment.
Product Performance and Market Reception:
Dentsply Sirona's products are generally well-received in the market, recognized for their quality, innovation, and reliability. The company regularly receives awards and accolades for its product portfolio. However, competition in the dental industry is fierce, and Dentsply Sirona faces continuous challenges from established players and new entrants.
Total Addressable Market:
The global dental market is estimated to be worth over $300 billion, with significant growth expected in the coming years due to factors such as rising disposable income, increasing awareness of oral health, and an aging population. This presents a substantial opportunity for Dentsply Sirona to expand its reach and market share.
Financial Performance:
(Data based on latest annual report)
- Revenue: $3.1 billion
- Net Income: $413 million
- Profit Margin: 13.3%
- Earnings per Share (EPS): $3.11
Dentsply Sirona has demonstrated consistent revenue growth over the past few years, with a healthy profit margin and respectable EPS. The company also maintains a strong balance sheet with a manageable debt level.
Dividends and Shareholder Returns:
Dividend History:
Dentsply Sirona has a history of paying dividends, with a current annualized dividend of $0.80 per share. The dividend payout ratio stands at around 25%, indicating the company's commitment to returning value to shareholders.
Shareholder Returns:
Over the past year, XRAY stock has delivered a total return of approximately 10%, outperforming the broader market. Long-term investors have also experienced significant returns, with a 10-year total return exceeding 150%.
Growth Trajectory:
Historical growth analysis reveals a steady upward trend for Dentsply Sirona, with consistent revenue and earnings growth over the past five years. The company's future growth prospects appear promising, driven by factors like new product launches, strategic acquisitions, and expanding into emerging markets.
Market Dynamics:
The dental industry is characterized by ongoing technological advancements, evolving consumer preferences, and increasing competition. Dentsply Sirona is actively adapting to these dynamics by focusing on innovation, digital solutions, and expanding its service offerings.
**Co
About Dentsply Sirona Inc
Exchange NASDAQ | Headquaters Charlotte, NC, United States | ||
IPO Launch date 1987-08-12 | CEO, President & Director Mr. Simon D. Campion | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 15000 | Website https://www.dentsplysirona.com |
Full time employees 15000 | Website https://www.dentsplysirona.com |
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.